Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Hangzhou Tigermed Consulting Co., Ltd. Class H ( (HK:3347) ).
Hangzhou Tigermed Consulting Co., Ltd. has announced the 2025 First H Share Class Meeting, scheduled for May 30, 2025, in Hangzhou, China. The meeting will consider a special resolution to grant the Board a general mandate to repurchase H Shares, which could impact the company’s share structure and market positioning.
More about Hangzhou Tigermed Consulting Co., Ltd. Class H
Hangzhou Tigermed Consulting Co., Ltd. is a joint stock company incorporated in the People’s Republic of China. It operates in the consulting industry, providing services primarily focused on clinical research and development for the pharmaceutical and biotechnology sectors.
YTD Price Performance: -19.13%
Average Trading Volume: 121
Technical Sentiment Signal: Buy
Current Market Cap: €3.88B
Learn more about 3347 stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue